SUSMAN SALLY 4

What Happened

• Sally Susman, a director of UL Solutions Inc. (ULS), was reported to have received three awards on June 8, 2026 totaling 14 derivative units (7 + 4 + 3). Each line is reported as a grant/award (transaction code A) with an acquisition price of $0.00. These are restricted stock units (RSUs) and/or deferred restricted stock units (DRSUs) that represent contingent rights to receive one share of ULS Class A common stock per unit.

Key Details

• Transaction date: June 8, 2026; Form 4 filed June 10, 2026 (filed within the standard two-business-day reporting window).
• Reported amounts: 7 RSU/DRSU; 4 RSU/DRSU; 3 RSU/DRSU — total 14 units; acquisition price $0.00 (award).
• Transaction code: A (Grant/Award/Other Acquisition).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Notable footnotes:
  • F1/F4/F8: Each RSU/DRSU represents a contingent right to one share and includes accrued dividend-equivalent rights.
  • F2/F6: Some entries represent accrual of dividend-equivalent rights on DRSUs/RSUs.
  • F3/F5: Certain DRSUs vested earlier (May 1, 2025 and May 20, 2026) and will be settled in shares on a date selected by the reporting person under the issuer’s Non-Employee Director Deferred Compensation Plan.
  • F7: Some RSUs vest on the earlier of May 20, 2027 or the first annual meeting following the May 20, 2026 grant date.
• Filing timeliness: Filing appears timely (filed within the two-business-day Form 4 requirement).

Context

• These are awards of restricted/deferred units (derivative securities), not open-market purchases or sales. RSU/DRSU grants are routine director compensation or deferred compensation elections and do not by themselves indicate buying or selling pressure. Vesting/settlement terms mean the director may receive shares later (or elect settlement timing under the Plan), per the footnotes.